SoftBank Corp. and Intelsat Launch Landmark Collaboration to Create Ubiquitous Network
17.9.2024 02:00:00 CEST | Business Wire | Press release
SoftBank Corp. (“SoftBank”) and Intelsat signed a groundbreaking collaboration agreement that will lead to the launch of a single “Ubiquitous Network” enabling customers to stay connected everywhere they go. SoftBank and Intelsat will jointly lead research and development of seamless 5G connections between terrestrial mobile networks and satellite communications networks.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240916589802/en/
In a society where everyone and everything is increasingly dependent on staying connected, convenient, and always-on, telecommunications are essential. However, despite the coming realization of autonomous mobility with automobiles, ships, drones and other vehicles, many areas are still without ground-based mobile network coverage and require separate devices and accounts to connect to non-terrestrial networks.
Through the new collaboration, SoftBank and Intelsat plan to jointly develop a hybrid communication solution that allows users to stay connected via available networks, whether terrestrial or satellite, anywhere in the world with the convenience of one device and one account. The solution will build on the same standard architectures, interfaces and processes that enable roaming of devices between terrestrial cellular networks today and will help make the commercial adoption of mobility solutions based on new 3GPP 5G standards for non-terrestrial networks a reality much sooner.
One of the key goals of the collaboration is to develop a universal device that will always stay connected regardless of where in the world it goes. For example, a future connected vehicle equipped with such a device will be able to seamlessly switch to a non-terrestrial satellite communication network when outside of terrestrial mobile network coverage. The targeted solution is expected to have wide commercial applicability, including in land mobile, maritime, and disaster response and recovery.
Design, development, field testing and commercialization of new hybrid network products between Intelsat and SoftBank will be conducted in phases, aligned with the development of the new 3GPP 5G non-terrestrial network standards. The resulting hybrid solutions will allow for existing satellite terminals to be used in the near term and newer 5G-based terminals as they become available.
“Intelsat and SoftBank share a pioneering vision of Ubiquitous Networking and seamless interoperability between satellite and terrestrial networks,” said Bruno Fromont, Intelsat Chief Technology Officer. “Until now, the challenge was aligning standards that allowed the two different networks to connect. With recent progress on 5G-based standardization of non-terrestrial networks led by Intelsat at 3GPP and this strategic collaboration with SoftBank, we are ideally positioned to accelerate the design and practical implementation of commercial hybrid services that will allow devices to freely roam between satellite and terrestrial networks.”
Hideyuki Tsukuda, Executive Vice President and CTO of SoftBank said, "By using technology that switches between terrestrial mobile networks and satellite communication networks through roaming, we can integrate the two previously separate networks and utilize satellite communication as an extension of mobile communication. Through this joint research and development, SoftBank and Intelsat will aim to build a Ubiquitous Network where people and things around the world can be connected to communication anytime, anywhere."
About Intelsat
Intelsat’s global team of professionals is focused on providing seamless and secure, satellite-based communications to government, NGO and commercial customers through the company’s next-generation worldwide network and managed services. Bridging the digital divide by operating one of the world’s largest and most advanced satellite fleet and connectivity infrastructures, Intelsat enables people and their tools to speak over oceans, see across continents and listen through the skies to communicate, cooperate and coexist. Since its founding six decades ago, the company has been synonymous with satellite-industry “firsts” in service to its customers and the planet. Leaning on a legacy of innovation and focusing on addressing a new generation of challenges Intelsat team members now have their sights on the “next firsts” in space as they disrupt the field and lead in the digital transformation of the industry.
About SoftBank Corp.
Guided by the SoftBank Group’s corporate philosophy, “Information Revolution – Happiness for everyone,” SoftBank Corp. (TOKYO: 9434) operates telecommunications and IT businesses in Japan and globally. In the fiscal year ended March 2024, SoftBank Corp. registered 6,084.0 billion yen of revenue, 876.1 billion yen of operating income and 489.1 billion yen of net income. SoftBank Corp. has 40 million mobile subscribers in Japan, and through its group companies, 63 million smartphone payment (PayPay) users, 85 million online media (Yahoo! JAPAN) users and 97 million communication app (LINE) users (as of May 9, 2024). Building on its strong business foundation, SoftBank Corp. is expanding into non-telecom fields in line with its “Beyond Carrier” growth strategy while further growing its telecom business by harnessing the power of 5G/6G, IoT, Digital Twin and Non-Terrestrial Network (NTN) solutions, including High Altitude Platform Station (HAPS)-based stratospheric telecommunications. While constructing AI data centers and developing homegrown LLMs specialized for the Japanese language with 1 trillion parameters, SoftBank is applying AI to enhance radio access network performance (AI-RAN) with the aim of becoming a provider of next-generation social infrastructure. In recognition of its ESG initiatives, SoftBank Corp. was selected for inclusion in the Dow Jones Sustainability World Index (DJSI World) for 2022 and 2023, achieving the highest score in Japan and registering as the only company in the country to be selected for the Telecommunication Services industry group in 2023. To learn more, please visit https://www.softbank.jp/en/.
Follow Us on Social Media:
Twitter/X: https://twitter.com/INTELSAT
LinkedIn: https://www.linkedin.com/company/intelsat
Instagram: https://www.instagram.com/intelsat/?hl=en
YouTube: https://www.youtube.com/user/intelsatmedia
View source version on businesswire.com: https://www.businesswire.com/news/home/20240916589802/en/
Contacts
Melissa Longo - melissa.longo@intelsat.com; +1 240-308-1881
Melissa Longo - melissa.longo@intelsat.com; +1 240-308-1881
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Murata Launches Ultra-Low Power AMR Sensors to Boost Battery Life in Healthcare and Wearables Devices27.4.2026 04:00:00 CEST | Press release
Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) has commenced mass production of its MRMS166R and MRMS168R anisotropic magnetoresistance (AMR) sensors for healthcare, wearable, and IoT devices. The MRMS166R is the first AMR sensor to combine an average current consumption of 20 nA with operation from a 1.2 V supply, enabling extended battery life in coin cell-powered systems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260413296947/en/ [Murata Manufacturing Co., Ltd.] AMR sensor The devices are solid-state magnetic sensors used for switching applications. They detect the presence or absence of a magnetic field and generate an output signal that system logic uses to control functions such as transitions between active and sleep modes. This enables contactless switching without mechanical components, improving reliability, and supporting sealed, miniaturized designs. Automatic switching between active and
Sun Pharma signs Definitive Agreement to Acquire Organon27.4.2026 01:51:00 CEST | Press release
Organon stockholders to receive US$ 14.00 per share in cashThe deal values Organon at EV of US$ 11.75 billionCombined Business leverages complementary portfolios and global scale for sustained long‑term value creation Sun Pharmaceutical Industries Limited(Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or associated companies, “Sun Pharma”) and Organon & Co. (NYSE: OGN) (“Organon”) today announced that they have entered into a definitive agreement under which Sun Pharma will acquire all outstanding shares of Organon for US$ 14.00 per share in an all‑cash transaction with an enterprise valuation of US$ 11.75 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260426881370/en/ Organon is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, in 2021. Organon has a legacy of deep trust and strong brand equit
Andersen Global udvider sin tilstedeværelse i Afrika med lanceringen af medlemsfirma i Cameroun26.4.2026 20:56:00 CEST | Pressemeddelelse
Andersen Global træder ind på det camerounske marked, idet Phoenix Advisory bliver medlemsfirma og overgår til Andersen-brandet. Andersen in Cameroun er et specialiseret rådgivningsfirma, der leverer strategiske, erhvervsmæssige, finansielle og operationelle rådgivningsydelser til organisationer i forskellige vækstfaser. Firmaet er grundlagt af fagfolk med erfaring fra store internationale organisationer og kombinerer et stærkt lokalt og centralafrikansk funderet kendskab til forretningsmæssige, juridiske og skattemæssige regler med en skræddersyet tilgang, der har til formål at skabe konkrete og målbare resultater for klienterne. "Overgangen til Andersen-brandet afspejler vores engagement i at vokse sammen med vores kunder og imødekomme stadig mere komplekse behov," udtalte administrerende partner Albert Désiré Zang. "Vi tror på, at langsigtet succes skabes gennem tillid, kvalitet og vedvarende support. At blive et medlemsfirma styrker vores evne til at levere gennemtænkte, bæredygtig
PMCOrganometallix Announces Price Increase on All Products24.4.2026 22:55:00 CEST | Press release
Due to significant changes in market conditions, PMC Organometallix, Inc. announces that effective May 1, 2026, or as contracts permit, prices across all product lines globally will increase by 10-25%. This adjustment is driven by sustained cost pressures from key inputs including rising raw material costs and escalating freight and logistics expenses. While the company has been absorbing these increases, the current economic environment brought on by the geopolitical crisis of the Iran conflict requires this adjustment to continue providing the high-quality, consistent materials and supply reliability that customers expect. PMC Organometallix will implement these changes in a transparent, collaborative manner and values your partnership while navigating these economic challenges. Customers with questions or to discuss a specific situation should contact their account representative. About PMC Group PMC Group is a growth-oriented, diversified, global chemicals and plastics company deli
Frankfurt Higher Regional Court upholds BESREMi® arbitral award in favor of AOP Health24.4.2026 18:52:00 CEST | Press release
Today, the Higher Regional Court of Frankfurt upheld the February 20251 partial final ICC arbitral award in favor of AOP Orphan Pharmaceuticals GmbH (“AOP Health”) in its dispute with PharmaEssentia Corp. (“PharmaEssentia”). The ruling confirms the award which found the Taiwanese company to be liable for certain damages. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260424005227/en/ Portrait Dr. Rudolf Widmann, Founder AOP Health Credit: AOP Health/Daniel Ospelt Dr. Rudolf Widmann, one of the two founders of AOP Health, explains: “We very much welcome the Frankfurt Higher Regional Court’s decision that confirms our position. In the interest of our patients, we are dedicated to maintaining stable and sustainable access to BESREMi® and to responsibly navigating future challenges.” The Product in Dispute The conflict centers around BESREMi® (ropeginterferon alfa-2b), a product launched in 2019 and developed by AOP Health into
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom